The trial did not meet its primary endpoint, however, the totality of data supports Barostim’s use as an effective treatment for patients with heart failure
February 22, 2023
CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial
February 22, 2023 — CVRx, Inc., a commercial-stage medical device company focused on developing, manufacturing and…
Read More
Integrated with the Rapid PE solution, Rapid RV/LV further accelerates time to triage and diagnose pulmonary embolism patients with right heart strain
February 22, 2023
RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Product
February 22, 2023 — RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and…
Read More
During the American College of Cardiology's 72nd Annual Scientific Session, “ACC Together with WCC,” five keynote presentations will feature premier experts covering issues facing all who deliver cardiovascular health care today. ACC.23/WCC will take place March 4-6 in New Orleans, LA.
February 22, 2023
Keynote Speakers to Address Timely Issues at ACC.23
February 22, 2023 — A range of hot topics will be the focus of five ACC23.WCC keynote presentations to be delivered…
Read More
First U.S. study to show lower risk in patients following SARS-CoV-2 infection
February 21, 2023
COVID-19 Vaccination Linked to Fewer Cardiac Events
February 21, 2023 — Analyzing the most extensive datasets in the United States, researchers from the Icahn School of…
Read More
A research analysis of individuals who had experienced strokes showed greater cerebral blood flow regulation during afternoon hours compared to morning and night times
February 21, 2023
Daily Rhythm Detected for Cerebral Blood Flow in Stroke Patients
February 21, 2023 — Strokes are a leading cause of morbidity and mortality in the United States, as well as around the…
Read More
February 21, 2023
AliveCor Announces the ITC’s Limited Exclusion Order Against Apple Clears Presidential Review
February 21, 2023 — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today…
Read More
NEXLETOL (bempedoic acid) is the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse cardiovascular events (MACE-4) primary endpoint –
February 20, 2023
Esperion Announces Positive CLEAR Outcomes Results To Be Presented as Late-Breaking Clinical Trial at ACC.23/WCC
February 20, 2023 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting …
Read More
A novel preclinical model of ischemic stroke suggests uric acid improves functional outcomes
February 20, 2023
SPAN Results, Monitoring Ischemic Stroke in Small- and Large-vessel Disease and Positive Neuroprotective Effects from Aptamer
February 20, 2023 — A novel Stroke Preclinical Assessment Network (SPAN) identified potential neuroprotective effects…
Read More
Keith Lowry, 68, of Dunbar, Pa is recovering well from the procedure.
February 17, 2023
Allegheny Health Network Cardiovascular Institute Completes 500th Heart Transplant
February 17, 2023 — Allegheny Health Network’s (AHN) Cardiovascular Institute reached a significant milestone in…
Read More
Jon A. Kobashigawa, MD
February 17, 2023
Renowned Cardiologist Honored for Medical Contributions in Heart Transplantation
February 17, 2023 — Internationally recognized cardiologist in heart transplantation Jon Kobashigawa, MD, director of…
Read More
Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV MRI SureScan defibrillation lead to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.
February 17, 2023
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
February 17, 2023 — Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan (…
Read More
The American College of Cardiology (ACC) has announced five Late-Breaking Clinical Trial Sessions, two Late-Breaking Clinical Trial Deep Dive Sessions, and three Featured Clinical Research sessions to be presented during its annual scientific session, “ACC with WCC,” or ACC.23/WCC to be held March 4-6 in New Orleans, LA.
Christine Book
February 16, 2023
Late-breaking Clinical Trials, Featured Clinical Research Sessions Announced for American College of Cardiology ACC.23/WCC
February 16, 2023 — The American College of Cardiology (ACC) has announced five Late-Breaking Clinical Trial Sessions,…
Read More
Noise-induced stress causes the release of stress hormones that trigger an inflammatory response, leading to more severe myocardial infarction, oxidative stress and endothelial dysfunction, and subsequent heart failure.
February 16, 2023
Aircraft Noise Increases Damage from Myocardial Infarction
February 16, 2023 — Traffic noise may play an essential role in the development and deterioration of ischemic heart…
Read More
Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters, announced this week it has received FDA 510(k) clearance for reprocessing the Philips IVUS Eagle Eye Platinum RX Digital catheter.
February 16, 2023
Northeast Scientific Inc. awarded 510(k) clearance to reprocess the Eagle Eye Platinum RX Digital IVUS Catheter
February 16, 2023 — Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters,…
Read More
Acute ischemic stroke patients with each PIRI score on 5-point scale
February 16, 2023
Percent Insular Ribbon Infarction for Growth Rate Prediction, Outcomes in Large-Vessel Occlusive Stroke
February 16, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR),…
Read More
The American College of Cardiology (ACC) will be joining with the World Heart Federation (WHF), in conjunction with the World Congress of Cardiology (WCC) for “ACC.23 Together with WCC,” to be held in New Orleans, LA, March 4 – 6, 2023. Program highlights for ACC.23/WCC are offered by the ITN team in this first of a multi-segment overview. Logo image courtesy of ACC.
Christine Book
February 15, 2023
American College of Cardiology Announces “ACC.23 Together with WCC” Program Highlights
February 15, 2023 — The American College of Cardiology (ACC) will be joining with the World Heart Federation (WHF), in…
Read More
Abbott and Cardiovascular Systems, Inc. (CSI), announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.
February 15, 2023
Abbott to Acquire Cardiovascular Systems, Inc.
February 15, 2023 — Abbott and Cardiovascular Systems, Inc. (CSI), announced a definitive agreement for Abbott to…
Read More
LACI-2 shows reduction in cognitive decline after lacunar stroke
February 15, 2023
ISC23 Late-breaker: A New Strategy to Improve Stroke Thrombolysis
February 15, 2023 — Thrombolysis use increased from 4% in 2010 to 14% in 2020 in the traditionally underserved urban…
Read More
The secure nationwide AI-powered cloud platform streamlines care team communication and delivers patient-specific imaging insights within clinical workflows
February 15, 2023
Nanox.AI Connects to Nuance Precision Imaging Network to Improve Early Detection of Chronic Diseases with Workflow-integrated AI
February 15, 2023 — Nano-X Imaging Ltd, an innovative medical imaging technology company, announced that its deep-…
Read More
VST-Bio's Collaborators Present Preclinical Trial Results at the American Heart Association International Stroke Conference in Dallas.
February 14, 2023
VST-BIO Announces Successful Preclinical Trials in Ischemic Stroke
February 14, 2023 — VST-Bio Corp. a leader in the development of innovative biologics to treat acute and chronic…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now